Clinical Trial Update: Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update for QLS-111-FDC in open-angle glaucoma and ocular hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• QLS-111-FDC

Snippet

Sponsor: Qlaris Bio, Inc. | Conditions: OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension | Phase 2, Phase 3 | Status: COMPLETED